The Prostate

Cover image for Vol. 74 Issue 7

Edited By: John T. Isaacs

Impact Factor: 3.843

ISI Journal Citation Reports © Ranking: 2012: 9/73 (Urology & Nephrology); 39/122 (Endocrinology & Metabolism)

Online ISSN: 1097-0045


Author Guidelines


NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement

For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.



Author Guidelines


All editorial correspondence should be sent to: Heather Wallace, Assistant Managing Editor, The Prostate Editorial Office, John Wiley & Sons, Inc., E-mail: TheProstate@wiley.com . The Journal requires that authors submit electronically via the online submission site at ScholarOne Manuscripts (formerly known as Manuscript Central).

Title page. This should contain the complete title of the paper: the names, titles, and affiliations of all authors; the institution at which the work was performed (specific to the department level); the name, address, telephone and fax numbers, and E-mail address for all correspondence; and a shortened title, not more than 40 characters, to be used as a running head. Each manuscript should have no more than nine authors. If a manuscript was worked on by a group, one or more authors may be named from this group. The other members of the group are not considered authors, but may be listed in an acknowledgment. Contract grant acknowledgment, giving the name of the contract grant sponsor and the contract grant number must be supplied, if applicable, as the last item of the title page. Other acknowledgments must be supplied at the end of the manuscript.

Disclosure Statement. All authors must disclose any affiliations that they consider to be relevant and important with any organization that to any author's knowledge has a direct interest, particularly a financial interest, in the subject matter discussed. Such affiliations inlcude, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with a company or its products. Other areas of real or perceived conflict of interest would include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations. This requirement will apply to every sort of article submitted to the Journal, including original research, reviews, editorials, letters to the editor, and any others, and should be disclosed at the time of submission. The simplest remedy for conflict of interest is disclosure. In the Journal, disclosure will henceforth be achieved by the inclusion of a short footnote with each published article. This information will be held in confidence while the paper is under review. It will not be shared with peer reviewers, and it will not influence the editorial decision to accept or reject the manuscript. When an article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be presented.

Abstract. This should be a factual condensation of the entire work structured into four paragraphs titled, Background , Methods , Results , and Conclusions . The abstract should not exceed 250 words.

Key words. Supply a list of 3 to 6 key words or phrases (not in title) that will adequately index the subject matter of the article.

Text. The text should follow the format: Introduction, Materials and Methods, Results, Discussion, and Conclusions. Use subheadings and paragraph titles whenever possible. Place Acknowledgments as the last element of the text, before the references. Text length should be within 25 double-spaced pages. Length limits include title page, abstract, body, references, and figure legends. Authors whose first language is not English should arrange for their manuscripts to be written in idiomatic English prior to submission. Please use American Style. If photographs of human subjects are used, a copy of the signed consent form must accompany the manuscript. Letters of permission must be submitted with any material that has previously been published.

Supporting Information: Supporting information will be published as submitted and will not be corrected or checked for scientific content, typographical errors or functionality. The responsibility for scientific accuracy and file functionality remains entirely with the authors. A disclaimer will be displayed to this effect with any supporting information published. Supporting information should always be provided in its final format, as it will not be copyedited or changed from its original format. It will not be available for review prior to publication. Supporting tables or figures may be made cited within the text and will be made available to readers at an online link; those additional files should be classified as supplemental files for review when the paper is submitted online.

References.

In the text, cite references as numerals in brackets. The final list should be in numerical order, by the order they appear in the text, and include full article titles, names of all authors (not et al.), and inclusive page numbers. Abbreviate journal names according to Index Medicus style. Note the following examples:

Journal articles:
Neri R. Pharmacology and pharmacokinetics of flutamide. Urology 1989;34:19-21.

Books:
2. Goldstein SR. Endovaginal ultrasound, 2nd ed. New York: Wiley-Liss; 1991. 1223 p.

Articles in books:
3. de Voogt HJ. Biology in the prostate. In: Smith PH, Pavone-Macaluso M, editors. Urological oncology: reconstructive surgery, organ conservation, and restoration of function. New York: Wiley-Liss; 1991. p 207-212.

Legends. A descriptive legend must accompany each illustration and must define all abbreviations used therein.

Tables. Each table must have a title. Tables should be numbered in order of appearance with Roman numerals and be referred to by number in the text.

Illustrations. Use illustrations sparingly. They should be numbered in one consecutive series using arabic numerals and be cited in order in the text. Four-color illustrations will be considered for publication. However, the author will be required to bear the cost of their publication. The charge for one page of color is $950. Second, and subsequent pages, up to four, will cost $500 each.

Rapid Communications

The Editorial Board will consider Rapid Communications upon completion of review. This will be published at no cost to the author. This report should contain the equivalent of six double-spaced typed pages (Including any figures, tables, or references) with generous margins.


Note to NIH Grantees. Pursuant to NIH mandate, Wiley-Blackwellwill post the accepted version of contributions authored by NIH grant-holdersto PubMed Central upon acceptance. This accepted version will be made publiclyavailable 12 months after publication. For further information, see www.wiley.com/go/nihmandate .




Guidelines for Electronic Submission

File Requirements:

Text. Must be submitted in Word (DOC or RTF). Do not embed tables or figures. Please include the title page, synopsis, abstract, main body, references, acknowledgements, and figure legends in a single file. Length should be within 25 double-spaced pages.

Tables. Must be created using the Table tool in Word (DOC or RTF). Each table must be in a separate file, and the files should be named by table # (i.e., table 1, table 2, etc.).

Figures. Each file must contain a single figure and be named by figure # (i.e., figure 1, figure 2, etc.). Files containing individual panels will not be accepted. Figures must be in TIFF or EPS. Resolution 1200 dpi for line art (simple bar graphs, charts, or non-photographic artwork) 600 dpi for combination halftones (photographs that also contain line art such as labeling or thin lines) 300 dpi for halftones (black and white photographs) and color figures.

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution Non-Commercial License OAA

Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

CONFLICT OF INTEREST

Please disclose all financial arrangements within the past two years, including consultancies, stock ownership, equity interest, patent-licensing agreements, research support, major honoraria, etc. you have with a company whose product figures prominently in the manuscript you are submitting, sending a letter to the editor, or providing an editorial. Please provide the same information for similar relationships with a company making a competing product to that which is featured in the manuscript. If the Editor finds that such activities raise the appearance of a conflict, he may recommend disclosure in a footnote. Otherwise, the information will remain confidential.

For additional details on manuscript and illustrations, please visit http://journalauthors.wiley.com


??? Production Questions ???

PROSprod@wiley.com

SEARCH

SEARCH BY CITATION